| Preliminary assessment of the efficacy of a t-cell–based influenza vaccine, MVA-NP+ M1, in humans PJ Lillie, TK Berthoud, TJ Powell, T Lambe, C Mullarkey, AJ Spencer, ... Clinical infectious diseases 55 (1), 19-25, 2012 | 295 | 2012 |
| Both neutralizing and non-neutralizing human H7N9 influenza vaccine-induced monoclonal antibodies confer protection CJH Dunand, PE Leon, M Huang, A Choi, V Chromikova, IY Ho, GS Tan, ... Cell host & microbe 19 (6), 800-813, 2016 | 288 | 2016 |
| Original antigenic sin: how first exposure shapes lifelong anti–influenza virus immune responses A Zhang, HD Stacey, CE Mullarkey, MS Miller The Journal of Immunology 202 (2), 335-340, 2019 | 189 | 2019 |
| Epitope specificity plays a critical role in regulating antibody-dependent cell-mediated cytotoxicity against influenza A virus W He, GS Tan, CE Mullarkey, AJ Lee, MMW Lam, F Krammer, C Henry, ... Proceedings of the National Academy of Sciences 113 (42), 11931-11936, 2016 | 188 | 2016 |
| Alveolar macrophages are critical for broadly-reactive antibody-mediated protection against influenza A virus in mice W He, CJ Chen, CE Mullarkey, JR Hamilton, CK Wong, PE Leon, ... Nature communications 8 (1), 846, 2017 | 165 | 2017 |
| Optimal activation of Fc-mediated effector functions by influenza virus hemagglutinin antibodies requires two points of contact PE Leon, W He, CE Mullarkey, MJ Bailey, MS Miller, F Krammer, P Palese, ... Proceedings of the National Academy of Sciences 113 (40), E5944-E5951, 2016 | 129 | 2016 |
| Coadministration of seasonal influenza vaccine and MVA-NP+ M1 simultaneously achieves potent humoral and cell-mediated responses RD Antrobus, TK Berthoud, CE Mullarkey, K Hoschler, L Coughlan, ... Molecular Therapy 22 (1), 233-238, 2014 | 127 | 2014 |
| Broadly neutralizing hemagglutinin stalk-specific antibodies induce potent phagocytosis of immune complexes by neutrophils in an Fc-dependent manner CE Mullarkey, MJ Bailey, DA Golubeva, GS Tan, R Nachbagauer, W He, ... MBio 7 (5), 10.1128/mbio. 01624-16, 2016 | 116 | 2016 |
| Broadly neutralizing anti-influenza virus antibodies: enhancement of neutralizing potency in polyclonal mixtures and IgA backbones W He, CE Mullarkey, JA Duty, TM Moran, P Palese, MS Miller Journal of virology 89 (7), 3610-3618, 2015 | 100 | 2015 |
| Immunity against heterosubtypic influenza virus induced by adenovirus and MVA expressing nucleoprotein and matrix protein-1 T Lambe, JB Carey, Y Li, AJ Spencer, A van Laarhoven, CE Mullarkey, ... Scientific reports 3 (1), 1443, 2013 | 91 | 2013 |
| IgA potentiates NETosis in response to viral infection HD Stacey, D Golubeva, A Posca, JC Ang, KE Novakowski, MA Zahoor, ... Proceedings of the National Academy of Sciences 118 (27), e2101497118, 2021 | 53 | 2021 |
| Improved adjuvanting of seasonal influenza vaccines: Preclinical studies of MVA‐NP+ M 1 coadministration with inactivated influenza vaccine CE Mullarkey, A Boyd, A van Laarhoven, EA Lefevre, B Veronica Carr, ... European journal of immunology 43 (7), 1940-1952, 2013 | 50 | 2013 |
| The generation of a simian adenoviral vectored HCV vaccine encoding genetically conserved gene segments to target multiple HCV genotypes A von Delft, TA Donnison, J Lourenço, C Hutchings, CE Mullarkey, ... Vaccine 36 (2), 313-321, 2018 | 45 | 2018 |
| Adenoviral vectors as novel vaccines for influenza L Coughlan, C Mullarkey, S Gilbert Journal of Pharmacy and Pharmacology 67 (3), 382-399, 2015 | 37 | 2015 |
| Neutrophils and influenza: a thin line between helpful and harmful ST George, J Lai, J Ma, HD Stacey, MS Miller, CE Mullarkey Vaccines 9 (6), 597, 2021 | 36 | 2021 |
| Measuring the neutralization potency of influenza A virus hemagglutinin stalk/stem-binding antibodies in polyclonal preparations by microneutralization assay W He, CE Mullarkey, MS Miller Methods 90, 95-100, 2015 | 36 | 2015 |
| T-Cell Responses in Children to Internal Influenza Antigens, 1 Year After Immunization With Pandemic H1N1 Influenza Vaccine, and Response to Revaccination With Seasonal … T Lambe, AJ Spencer, CE Mullarkey, RD Antrobus, LM Yu, P de Whalley, ... The Pediatric infectious disease journal 31 (6), e86-e91, 2012 | 27 | 2012 |
| Novel bivalent viral-vectored vaccines induce potent humoral and cellular immune responses conferring protection against stringent influenza A virus challenge CM Tully, S Chinnakannan, CE Mullarkey, M Ulaszewska, F Ferrara, ... The Journal of Immunology 199 (4), 1333-1341, 2017 | 21 | 2017 |
| Game on: immersive virtual laboratory simulation improves student learning outcomes & motivation D Tsirulnikov, C Suart, R Abdullah, F Vulcu, CE Mullarkey FEBS Open bio 13 (3), 396-407, 2023 | 12 | 2023 |
| Fc-dependent effector functions of neutrophils induced by hemagglutinin stalk-specific antibodies CE Mullarkey, MJ Bailey, D Golubeva, K Azarm, R Nachbagauer, ... The Journal of Immunology 196 (1_Supplement), 146.17-146.17, 2016 | 1 | 2016 |
